Belite Bio, Inc (BLTE)
NASDAQ: BLTE · Real-Time Price · USD
65.68
-1.02 (-1.53%)
Mar 31, 2025, 1:41 PM EDT - Market open
Belite Bio Market Cap
Belite Bio has a market cap or net worth of $2.09 billion as of March 31, 2025. Its market cap has increased by 88.68% in one year.
Market Cap
2.09B
Enterprise Value
1.98B
1-Year Change
88.68%
Ranking
Category
Stock Price
$65.68
Market Cap Chart
Since the IPO on April 29, 2022, Belite Bio's market cap has increased from $144.57M to $2.09B, an increase of 1,346.41%. That is a compound annual growth rate of 150.05%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 28, 2025 | 2.12B | 8.99% |
| Dec 31, 2024 | 1.95B | 54.32% |
| Dec 29, 2023 | 1.26B | 68.44% |
| Dec 30, 2022 | 749.63M | 418.52% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 738.61B |
| UnitedHealth Group | 472.03B |
| Johnson & Johnson | 394.52B |
| AbbVie | 363.15B |
| Novo Nordisk | 305.46B |
| AstraZeneca | 229.16B |
| Abbott Laboratories | 226.88B |
| Merck & Co. | 225.40B |